Spearhead Capital Advisors, LLC Abb Vie Inc. Transaction History

Spearhead Capital Advisors, LLC

$92.3 Million
Q3 2022

A detailed history of Spearhead Capital Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Spearhead Capital Advisors, LLC holds 7,093 shares of ABBV stock, worth $1.28 Million. This represents 1.03% of its overall portfolio holdings.

Number of Shares

7,093

Previous 64,961 89.08%

Holding current value

$1.28 Million

Previous $9.95 Million 90.43%

% of portfolio

1.03%

Previous 1.48%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	SELL	$134.21 - $153.93 $7.77 Million - $8.91 Million	-57,868 Reduced 89.08%	7,093 $952,000
Q2 2022 Aug 10, 2022	SELL	$137.62 - $174.96 $2.13 Million - $2.71 Million	-15,510 Reduced 19.27%	64,961 $9.95 Million
Q1 2022 Apr 28, 2022	SELL	$131.98 - $163.75 $588,234 - $729,833	-4,457 Reduced 5.25%	80,471 $13 Million
Q4 2021 Jan 25, 2022	BUY	$107.43 - $135.93 $246,659 - $312,095	2,296 Added 2.78%	84,928 $11.5 Million
Q3 2021 Oct 27, 2021	BUY	$106.4 - $120.78 $1.16 Million - $1.31 Million	10,880 Added 15.16%	82,632 $8.91 Million
Q2 2021 Aug 10, 2021	BUY	$105.21 - $117.21 $160,340 - $178,628	1,524 Added 2.17%	71,752 $8.08 Million
Q1 2021 Apr 28, 2021	BUY	$102.3 - $112.62 $157,542 - $173,434	1,540 Added 2.24%	70,228 $7.6 Million
Q4 2020 Feb 02, 2021	BUY	$80.49 - $108.67 $492,276 - $664,625	6,116 Added 9.77%	68,688 $7.36 Million
Q3 2020 Oct 16, 2020	BUY	$85.91 - $100.83 $103,865 - $121,903	1,209 Added 1.97%	62,572 $5.48 Million
Q2 2020 Jul 16, 2020	BUY	$73.37 - $98.18 $261,930 - $350,502	3,570 Added 6.18%	61,363 $6.03 Million
Q1 2020 Apr 17, 2020	SELL	$64.5 - $97.79 $12,835 - $19,460	-199 Reduced 0.34%	57,793 $4.4 Million
Q4 2019 Feb 06, 2020	SELL	$72.13 - $90.25 $57,271 - $71,658	-794 Reduced 1.35%	57,992 $5.14 Million
Q3 2019 Oct 21, 2019	BUY	$62.98 - $75.72 $485,827 - $584,104	7,714 Added 15.1%	58,786 $4.45 Million
Q2 2019 Jul 17, 2019	BUY	$65.7 - $83.98 $440,978 - $563,673	6,712 Added 15.13%	51,072 $3.71 Million
Q1 2019 Apr 23, 2019	BUY	$77.14 - $90.79 $720,101 - $847,524	9,335 Added 26.65%	44,360 $3.58 Million
Q4 2018 Feb 07, 2019	SELL	$77.85 - $96.01 $115,529 - $142,478	-1,484 Reduced 4.06%	35,025 $3.23 Million
Q3 2018 Oct 11, 2018	BUY	$88.91 - $98.84 $100,646 - $111,886	1,132 Added 3.2%	36,509 $3.46 Million
Q2 2018 Jul 25, 2018	BUY	$89.78 - $106.23 $254,526 - $301,162	2,835 Added 8.71%	35,377 $3.28 Million
Q1 2018 Apr 12, 2018	BUY	$92.01 - $123.21 $476,243 - $637,734	5,176 Added 18.91%	32,542 $3.08 Million
Q4 2017 Jan 23, 2018	BUY	$89.56 - $98.21 $2.45 Million - $2.69 Million	27,366	27,366 $2.65 Million

Others Institutions Holding ABBV

# of Institutions

3,849

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $320B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Spearhead Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spearhead Capital Advisors, LLC with notifications on news.

Account

Spearhead Capital Advisors, LLC Abb Vie Inc. Transaction History